In summary, these studies indicate a prognostic significance for CXCL1 expression in breast cancer stroma, show that CXCL1 is localized to multiple fibroblast populations, and is negatively regulated by TGF-β signaling. The gene discussed is TGFB1; the disease is breast cancer.